|
| 38051788 | The immunogenicity of an HIV-1 Gag conserved element DNA vaccine in people with HIV and receiving antiretroviral therapy. | AIDS | 2024 |
| 36913789 | Duration of viral infectiousness and correlation with symptoms and diagnostic testing in non-hospitalized adults during acute SARS-CoV-2 infection: A longitudinal cohort study. | J Clin Virol | 2023 |
| 36348617 | Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study. | Journal of Infectious Diseases | 2023 |
| 38016958 | Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01. | | 2023 |
| 37733596 | Ultrasound-guided lymph node fine-needle aspiration for evaluating post-vaccination germinal center responses in humans. | | 2023 |
| 37811993 | Mosaic HIV-1 vaccination induces anti-viral CD8 T cell functionality in the phase 1/2a clinical trial APPROACH. | | 2023 |
| 38096385 | HIV vaccines induce CD8<sup>+</sup> T cells with low antigen receptor sensitivity. | Science | 2023 |
| 37795976 | Protein dose-sparing effect of AS01B adjuvant in a randomized preventive HIV vaccine trial of ALVAC-HIV (vCP2438) and adjuvanted bivalent subtype C gp120. | J Infect Dis | 2023 |
| 37552991 | mRNA vaccination boosts S-specific TÂ cell memory and promotes expansion of CD45RA T-like CD8 TÂ cells in COVID-19 recovered individuals. | | 2023 |
| 37289667 | Cross-protocol assessment of induction and durability of VISP/R in HIV preventive vaccine trial participants. | PLOS Glob Public Health | 2023 |
| 37020953 | Upregulation of IFN-stimulated genes persists beyond the transitory broad immunologic changes of acute HIV-1 infection. | iScience | 2023 |
| 36572838 | Author Correction: The persistence of memory: defining, engineering, and measuring vaccine durability. | Nat Immunol | 2023 |
| 37195999 | Distinct immune responses associated with vaccination status and protection outcomes after malaria challenge. | PLoS Pathog | 2023 |
| 37384759 | Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials. | | 2023 |
| 37300931 | Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition. | EBioMedicine | 2023 |
| 36993183 | Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming. | | 2023 |
| 37296110 | Persistent serum protein signatures define an inflammatory subcategory of long COVID. | Nat Commun | 2023 |
| 36787249 | Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults. | | 2023 |
| 37224227 | A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses. | | 2023 |
| 35138909 | Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency. | Sci Transl Med | 2022 |
| 35397867 | COVID-19 vaccination and HIV-1 acquisition - Authors' reply. | Lancet, The | 2022 |
| 36045906 | Leveraging lessons learned from the COVID-19 pandemic for HIV. | | 2022 |
| 36179551 | Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens. | EBioMedicine | 2022 |
| 35507661 | Characterization of a vaccine-elicited human antibody with sequence homology to VRC01-class antibodies that binds the C1C2 gp120 domain. | Science advances | 2022 |
| 35758878 | Analysis of the HIV Vaccine Trials Network 702 Phase 2b-3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk. | J Infect Dis | 2022 |
| 35803696 | Th2-Biased Transcriptional Profile Predicts HIV Envelope-Specific Polyfunctional CD4<sup>+</sup> T Cells That Correlated with Reduced Risk of Infection in RV144 Trial. | J Immunol | 2022 |
| 35866359 | Achieving intracellular cytokine staining assay concordance on two continents to assess HIV vaccine-induced T-cell responses. | Journal of Leukocyte Biology | 2022 |
| 36268023 | Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELDâ¿¢ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian adults. | Front Immunol | 2022 |
| 36197845 | First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study. | PLoS ONE | 2022 |
| 35927399 | Impact of adjuvants on the biophysical and functional characteristics of HIV vaccine-elicited antibodies in humans. | npj Vaccines | 2022 |
| 35547849 | Safety and Immunogenicity of a Third Dose of SARS-CoV-2 mRNA Vaccine - An Interim Analysis. | | 2022 |
| 37091190 | The quest for vaccine-induced immune correlates of protection against tuberculosis. | | 2022 |
| 36591224 | Longitudinal immune profiling after radiation-attenuated sporozoite vaccination reveals coordinated immune processes correlated with malaria protection. | Front Immunol | 2022 |
| 36456737 | The persistence of memory: defining, engineering, and measuring vaccine durability. | Nat Immunol | 2022 |
| 36454825 | Vaccination induces HIV broadly neutralizing antibody precursors in humans. | Science | 2022 |
| 35035955 | Whole-blood cytokine secretion assay as a high-throughput alternative for assessing the cell-mediated immunity profile after two doses of an adjuvanted SARS-CoV-2 recombinant protein vaccine candidate. | Clinical and Translational Immunology | 2022 |
| 35015777 | Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial. | PLoS Medicine | 2022 |
| 35108339 | Systems analysis of immune responses to attenuated P. falciparum malaria sporozoite vaccination reveals excessive inflammatory signatures correlating with impaired immunity. | PLoS Pathog | 2022 |
| 35081293 | Homologous and Heterologous Covid-19 Booster Vaccinations. | N Engl J Med | 2022 |
| 35060479 | Transcriptional correlates of malaria in RTS,S/AS01-vaccinated African children: a matched case-control study. | Elife | 2022 |
| 35262071 | BCG revaccination qualitatively and quantitatively enhances SARS-CoV-2 spike-specific neutralizing antibody and T cell responses induced by the COVISHIELD<sup>â¿¢</sup> vaccine in SARS-CoV-2 seronegative young Indian adults. | Res Sq | 2022 |
| 34486798 | Machine learning identifies molecular regulators and therapeutics for targeting SARS-CoV2-induced cytokine release. | Molecular Systems Biology | 2021 |
| 34237283 | Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects. | Cell Rep | 2021 |
| 34075380 | Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence. | bioRxiv | 2021 |
| 33859204 | Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans. | NPJ Vaccines | 2021 |
| 33481787 | Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial. | PLoS ONE | 2021 |
| 34229888 | AIDSVAX protein boost improves breadth and magnitude of vaccine-induced HIV-1 envelope-specific responses after a 7-year rest period. | Vaccine | 2021 |
| 34166231 | Rectal tissue and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challenge. | J Clin Invest | 2021 |
| 34062119 | Integrated analysis of multimodal single-cell data. | Cell | 2021 |
| 33791692 | Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects. | bioRxiv | 2021 |